Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
It is odd how some shares fly ahead of a bullish research note only to slip back when it is published. I can’t think why that would happen. Those who insisted that forecasts for Skinbiotherapeutics (SBTX) did not allow for Indian upside on its first acquisition should perhaps look away now. That was tummy rot. None the less this new Cavendish note is credible and serious. But as ever it comes down to Croda. If that jv flies we will all be rich. If it does not then we won’t. It’s a binary bet but on a risk reward basis a very good one in my view. Enough of me. Cavendish opines:
Already a member? Sign in
• All premium articles
• Tom Winnifrith’s Bearcast
• Access to all the entire nearly 13 year archive
• ShareProphets Daily Newsletter
Cancel any time
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.